166 related articles for article (PubMed ID: 9201668)
21. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and acceptability of amineptine versus fluoxetine in major depression.
Dalery J; Rochat C; Peyron E; Bernard G
Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S35-8. PubMed ID: 9347391
[TBL] [Abstract][Full Text] [Related]
23. A multicentre open trial of fluoxetine in depressed out-patients in Belgium.
Brasseur R
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():107-11. PubMed ID: 2644335
[TBL] [Abstract][Full Text] [Related]
24. Tolerability and safety: essentials in antidepressant pharmacotherapy.
Lader MH
J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
[TBL] [Abstract][Full Text] [Related]
25. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
26. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
28. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
Brambilla P; Cipriani A; Hotopf M; Barbui C
Pharmacopsychiatry; 2005 Mar; 38(2):69-77. PubMed ID: 15744630
[TBL] [Abstract][Full Text] [Related]
29. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
30. Fluoxetine tenth anniversary update: the progress continues.
Stokes PE; Holtz A
Clin Ther; 1997; 19(5):1135-250. PubMed ID: 9385500
[TBL] [Abstract][Full Text] [Related]
31. Economic appraisal of citalopram in the management of single-episode depression.
Sclar DA; Skaer TL; Robison LM; Galin RS
J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
[TBL] [Abstract][Full Text] [Related]
32. Contemporary management of depression.
Andrews JM; Nemeroff CB
Am J Med; 1994 Dec; 97(6A):24S-32S. PubMed ID: 7992823
[TBL] [Abstract][Full Text] [Related]
33. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
[TBL] [Abstract][Full Text] [Related]
34. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
[TBL] [Abstract][Full Text] [Related]
35. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy.
Goodnick PJ
Ann Clin Psychiatry; 2001 Mar; 13(1):31-41. PubMed ID: 11465683
[TBL] [Abstract][Full Text] [Related]
36. [Fluoxetine: an update of its use in major depressive disorder in adults].
Gourion D; Perrin E; Quintin P
Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
[TBL] [Abstract][Full Text] [Related]
37. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
[TBL] [Abstract][Full Text] [Related]
38. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
[TBL] [Abstract][Full Text] [Related]
40. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
